These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3064242)

  • 1. [Cholesterol--the main risk factor in ischemic heart disease].
    Heyden S; Kroos S
    Schweiz Rundsch Med Prax; 1988 Nov; 77(48):1312-7. PubMed ID: 3064242
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercholesterolemia: a reversible risk factor for coronary heart disease.
    Mishkel MA
    CMAJ; 1989 Feb; 140(4):419. PubMed ID: 2644008
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypercholesterolemia: to treat or not to treat? That is the question].
    Ducobu J
    Rev Med Brux; 1994; 15(3):124-31. PubMed ID: 8066357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting tough with cholesterol.
    Harv Heart Lett; 1998 Feb; 8(6):1-4. PubMed ID: 9516312
    [No Abstract]   [Full Text] [Related]  

  • 5. The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
    Leake NB
    Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evidence of the efficacy of hypocholesterolemic treatment in primary and secondary prevention of ischemic heart disease].
    Alvarez-Sala Walther LA; Millán Núñez-Cortés J
    Med Clin (Barc); 2000; 114 Suppl 2():1-10. PubMed ID: 10916798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cholesterol question. Disinformed information].
    Bobbio M; Brusca A
    G Ital Cardiol; 1991 Sep; 21(9):1029-33. PubMed ID: 1790828
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid therapy. Goal and use in prevention of coronary heart disease].
    Windler E; Greten H
    Internist (Berl); 1996 Dec; 37(12):1244-8. PubMed ID: 9081925
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hypercholesterolemia in patients with known coronary artery disease.
    Schlant RC
    Heart Dis Stroke; 1993; 2(5):373-6. PubMed ID: 8137037
    [No Abstract]   [Full Text] [Related]  

  • 11. Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention.
    Labreche DG
    Clin Pharm; 1988 Aug; 7(8):592-603. PubMed ID: 3048850
    [No Abstract]   [Full Text] [Related]  

  • 12. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view.
    Crouch MA
    J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369
    [No Abstract]   [Full Text] [Related]  

  • 13. Profiling a landmark clinical trial: Scandinavian Simvastatin Survival Study.
    Guptha S
    Curr Opin Lipidol; 1995 Oct; 6(5):251-3. PubMed ID: 8520845
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients?
    Adelman A
    J Fam Pract; 2001 Nov; 50(11):924. PubMed ID: 11711002
    [No Abstract]   [Full Text] [Related]  

  • 16. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
    Fruchart JC
    Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
    [No Abstract]   [Full Text] [Related]  

  • 17. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High cholesterol levels in healthy seniors: cause for concern?
    Drown DJ
    Prog Cardiovasc Nurs; 1995; 10(1):40-1. PubMed ID: 7770441
    [No Abstract]   [Full Text] [Related]  

  • 20. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM; Kuller LH
    Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.